Chemistry for biology and medicine
Ideas where chemistry meets biology and medicine, such as chemical biology, medicinal chemistry, imaging probes, diagnostics and biomedical research tools.
Who funds this idea
13 calls from 5 funders currently fund work on this idea. Most calls: NIH (7), European Commission (Horizon Europe) (2), NSF (2), UKRI research councils (1), HHS ASPR – Biomedical Advanced Research and Development Authority (BARDA) (1).3 calls for this idea welcome industry or international partners
Open now (12)
Advanced Materials for Miniaturised Energy Harvesting Systems
Deadline: 28 Oct 2026 (6 days)
materialsenergy & batteriesestablished / PI
Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 Clinical Trial Not Allowed, PAR-27-067)
Deadline: 26 Jan 2027 (96 days)
chemistrymaterialspharma processestablished / PIearly-careerinstrument / beamtime
Small molecule high throughput screen using AstraZeneca facilities
Deadline: 28 Jan 2027 (98 days)
chemistrypharma processestablished / PI
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: 05 Mar 2027 (134 days)
chemistrypharma processestablished / PI
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Deadline: 05 Apr 2027 (165 days)
chemistryestablished / PIindustry / SMEsmall business (SBIR/STTR, EIC Accelerator)
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed, PAR-27-021)
Deadline: 01 Jul 2027 (252 days)
chemistrymaterialspharma processestablished / PIearly-careerinstrument / beamtime
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: 05 Nov 2027 (379 days)
chemistrypharma processestablished / PI
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Deadline: 07 Jan 2028 (442 days)
chemistrypharma processestablished / PI
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Deadline: 20 Feb 2029 (852 days)
chemistrypharma processestablished / PI
BARDA Broad Agency Announcement (medical countermeasures, incl. manufacturing platforms)
Deadline: Areas of interest listed; no closing date on the page – check the funder page
pharma processindustry / SME
Chemical Process Systems (CPS)
Deadline: Rolling / no fixed deadline
chemistrymaterialsestablished / PI
Engineering (ENG): Chemical, Bioengineering, Energy, and Transport Systems (CBET)
Deadline: Rolling / no fixed deadline
chemistrymaterialsestablished / PI
Opening soon (1)
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Opening soon: not yet open
Deadline: 17 Feb 2027 (118 days)
chemistrypharma processestablished / PI
Recently funded work on this idea
61 awards from NSF and NIH in our sample of the last 24 months match this idea. Latest examples:
| Award (official page) | Institution | Amount | Start date |
|---|---|---|---|
| Developing GFRA2 as an optimal immunotherapeutic target for neuroblastoma and Ewing sarcoma | Children'S Hosp Of Philadelphia | $109,364 | 23 Sep 2026 |
| CAREER: 3D One-step Heterogeneous Manufacturing for Integrated Circuits (3D OHMIC) | University of Connecticut | $549,994 | 01 Sep 2026 |
| MRI: Track 1 Acquisition of a CPAD X-ray Diffractometer for Chemical and Biochemical Research and Education | Vassar College | $449,931 | 01 Sep 2026 |
| Anion Binding in Chiral Cyclotribenzoin Esters | University of Houston | $525,620 | 01 Sep 2026 |